We test INF on three datasets retrieved from the TCGA repository, to predict either the estrogen receptor status (ER) or the cancer subtype on the breast invasive carcinoma (BRCA) dataset, and to predict the overall survival (OS) on the kidney renal clear cell carcinoma (KIRC) and acute myeloid leukemia (AML) datasets. The gene discussed is ESR1; the disease is invasive breast carcinoma.